首页> 美国卫生研究院文献>other >Nasolacrimal recanalization as an alternative to external dacryocystorhinostomy for treating failed nasolacrimal duct intubation
【2h】

Nasolacrimal recanalization as an alternative to external dacryocystorhinostomy for treating failed nasolacrimal duct intubation

机译:鼻泪再通术可替代外部泪囊鼻腔吻合术治疗失败的鼻泪管插管

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To compare the surgical duration and clinical outcomes of nasolacrimal recanalization versus external dacryocystorhinostomy (DCR) in the treatment of failed nasolacrimal duct intubation.This is a retrospective, comparative, and interventional study. We evaluated the outcomes of 66 consecutive patients undergoing either nasolacrimal recanalization (n = 32) or DCR (n = 34) in a tertiary lacrimal disease referral center. Length of surgical duration, clinical outcomes, and rate of recurrence at 18 months postoperatively were compared.The mean surgical duration was 18.5 minutes (range, 15–25 minutes) for nasolacrimal recanalization and 48.2 minutes (range, 45–61 minutes) for DCR, respectively (P < 0.001). The rate of success was 84.4% in the recanalization group and 85.3% in the DCR group, respectively (P = 0.91). The time to recurrence was 2.6 ± 1.1 months in the recanalization group and 5.6 ± 2.1 months in the DCR group (P < 0.001). Five failed cases in each group received a secondary DCR surgery with the same resolution rate (40%). The absence of ocular discharge at baseline was a significant predictor for a successful outcome in the recanalization group (P = 0.04) but not in the DCR group (P = 0.63).Nasolacrimal recanalization is an effective, safe, and time-saving alternative to DCR for the treatment of failed nasolacrimal duct intubation. Clinicians should be cautious in patients with discharge.
机译:为了比较鼻泪再通术与外部泪囊鼻腔吻合术(DCR)在失败的鼻泪管插管治疗中的手术时间和临床结果,这是一项回顾性,比较性和介入性研究。我们评估了三级泪腺疾病转诊中心接受鼻泪再通(n = 32)或DCR(n = 34)的66位连续患者的结局。比较了手术时间的长度,临床结局和术后18个月的复发率。鼻泪再通的平均手术时间为18.5分钟(15-25分钟),而DCR的平均手术时间为48.2分钟(45-61分钟)。 ,分别为(P <0.001)。再通组的成功率为84.4%,DCR组的成功率为85.3%(P = 0.91)。再通组的复发时间为2.6±1.1个月,而DCR组为5.6±2.1个月(P(<0.001)。每组中有5例失败的病例接受了相同分辨率(40%)的二次DCR手术。在再通组中,基线时不存在眼部放血是成功预后的重要预测指标(P = 0.04),而在DCR组则不行(P = 0.63)。鼻泪再通是一种有效,安全且省时的替代方法DCR用于治疗失败的鼻泪管插管。出院患者应谨慎对待临床医生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号